USPTO Patent Application: Negative Pressure Wound Therapy Self-Testing
Summary
The USPTO has published a patent application (US20260083899A1) for a negative pressure wound therapy device with self-testing capabilities. The application details a system that includes a negative pressure source, valve, flow restrictor, pressure sensor, and control circuitry for performing leak, flow, or excessive pressure tests.
What changed
This document is a USPTO patent application (US20260083899A1) for a negative pressure wound therapy (NPWT) device. The application, filed on December 3, 2025, and published on March 26, 2026, describes a novel system incorporating self-testing features. These features include a valve, flow restrictor, pressure sensor, and control circuitry designed to perform leak, flow, or excessive pressure tests, enhancing device reliability and potentially patient safety.
As this is a patent application, it does not impose direct compliance obligations on medical device manufacturers. However, it signifies innovation in the NPWT field. Companies developing or manufacturing NPWT devices should be aware of this patent filing as it may impact future product development, intellectual property strategies, and competitive landscape within the medical device sector.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SELF-TESTING FOR NEGATIVE PRESSURE WOUND THERAPY DEVICES
Application US20260083899A1 Kind: A1 Mar 26, 2026
Inventors
Ben Alan Askem, David Michael Elder, Danielle Susan Johnson, Camilo Patrick Madriz, Andrea Maggiore, Christopher John Webb
Abstract
A negative pressure wound therapy device can include a negative pressure source configured to be connected, via a fluid flow path, to a wound, a valve positioned in the fluid flow path and configured to, in an open state, permit supply of negative pressure from the negative pressure source upstream of the valve and, in a closed state, block supply of negative pressure from the negative pressure source upstream of the valve, a flow restrictor positioned in the fluid flow path, and a pressure sensor configured to measure a pressure differential across the flow restrictor. The device can include control circuitry configured to, in a normal operational mode, cause the valve to be in the open state and, in a test mode, perform at least one of a leak test, a flow test, or an excessive pressure test.
CPC Classifications
A61M 1/918 A61M 1/743 A61M 1/98 A61M 2205/15 A61M 2205/3331 A61M 2205/70
Filing Date
2025-12-03
Application No.
19407401
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.